Status:
COMPLETED
Observational Study of Elizaria® in aHUS Patients
Lead Sponsor:
AO GENERIUM
Conditions:
Atypical Hemolytic Uremic Syndrome
aHUS
Eligibility:
All Genders
2+ years
Brief Summary
It is a multicenter observational non-comparative study of the efficacy and safety of long-term pathogenetic Elizaria® therapy in patients with atypical Hemolytic Uremic Syndrome
Detailed Description
After screening, patients meeting all of the inclusion / non-inclusion criteria and vaccinated against meningococcal infections were treated by Elizaria®. The study is planned to include at least 50 ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Written informed consent to study participation.
- Male and female patients aged 2 months and older with documented atypical hemolytic uremic syndrome (aHUS)diagnosis.
- By the time of inclusion in the study, Elizaria® should be prescribed as a pathogenetic therapy for aHUS; Exclusion Criteria
- 1\. Intolerance to eculizumab, or other components of the drug.
Exclusion
Key Trial Info
Start Date :
December 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04749810
Start Date
December 19 2019
End Date
April 30 2022
Last Update
August 4 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation
Kazan', Russia, 420012
2
Regional State Budgetary Healthcare Institution "Krasnoyarsk' Regional Clinical Center for Maternity and Childhood Protection"
Krasnoyarsk, Russia, 660074
3
State budgetary healthcare institution of the city of Moscow "Children's City Clinical Hospital of St. Vladimir of the Healthcare Department of the City of Moscow"
Moscow, Russia, 107014
4
Federal State Autonomous Educational Institution of Higher Education "First Moscow State Medical University n.a. I.M. Sechenov" of the Ministry of Health of the Russian Federation
Moscow, Russia, 119991